385 related articles for article (PubMed ID: 35120436)
1. A randomized controlled clinical trial of prolonged balloon inflation during stent deployment strategy in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a pilot study.
Ma M; Wang L; Diao KY; Liang SC; Zhu Y; Wang H; Wang M; Zhang L; Yang ZG; He Y
BMC Cardiovasc Disord; 2022 Feb; 22(1):30. PubMed ID: 35120436
[TBL] [Abstract][Full Text] [Related]
2. Cardiac magnetic resonance derived late microvascular obstruction assessment post ST-segment elevation myocardial infarction is the best predictor of left ventricular function: a comparison of angiographic and cardiac magnetic resonance derived measurements.
Wong DT; Leung MC; Richardson JD; Puri R; Bertaso AG; Williams K; Meredith IT; Teo KS; Worthley MI; Worthley SG
Int J Cardiovasc Imaging; 2012 Dec; 28(8):1971-81. PubMed ID: 22310980
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of deferred stenting versus immediate stenting to prevent no- or slow-reflow in acute ST-segment elevation myocardial infarction (DEFER-STEMI).
Carrick D; Oldroyd KG; McEntegart M; Haig C; Petrie MC; Eteiba H; Hood S; Owens C; Watkins S; Layland J; Lindsay M; Peat E; Rae A; Behan M; Sood A; Hillis WS; Mordi I; Mahrous A; Ahmed N; Wilson R; Lasalle L; Généreux P; Ford I; Berry C
J Am Coll Cardiol; 2014 May; 63(20):2088-2098. PubMed ID: 24583294
[TBL] [Abstract][Full Text] [Related]
4. Identification of High-Risk Patients After ST-Segment-Elevation Myocardial Infarction: Comparison Between Angiographic and Magnetic Resonance Parameters.
Durante A; Laricchia A; Benedetti G; Esposito A; Margonato A; Rimoldi O; De Cobelli F; Colombo A; Camici PG
Circ Cardiovasc Imaging; 2017 Jun; 10(6):e005841. PubMed ID: 28592591
[TBL] [Abstract][Full Text] [Related]
5. No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction.
Gupta S; Gupta MM
Indian Heart J; 2016; 68(4):539-51. PubMed ID: 27543480
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of Mean Platelet Volume-to-Lymphocyte Ratio for Predicting Angiographic No-Reflow and Short-Term Prognosis After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction.
Kurtul A; Acikgoz SK
Am J Cardiol; 2017 Aug; 120(4):534-541. PubMed ID: 28633762
[TBL] [Abstract][Full Text] [Related]
7. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
[TBL] [Abstract][Full Text] [Related]
8. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
[No Abstract] [Full Text] [Related]
9. Invasive Assessment of the Coronary Microcirculation in Reperfused ST-Segment-Elevation Myocardial Infarction Patients: Where Do We Stand?
Bulluck H; Foin N; Tan JW; Low AF; Sezer M; Hausenloy DJ
Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28242607
[TBL] [Abstract][Full Text] [Related]
10. INNOVATION Study (Impact of Immediate Stent Implantation Versus Deferred Stent Implantation on Infarct Size and Microvascular Perfusion in Patients With ST-Segment-Elevation Myocardial Infarction).
Kim JS; Lee HJ; Woong Yu C; Kim YM; Hong SJ; Park JH; Choi RK; Choi YJ; Park JS; Kim TH; Jang HJ; Joo HJ; Cho SA; Ro YM; Lim DS
Circ Cardiovasc Interv; 2016 Dec; 9(12):. PubMed ID: 27965296
[TBL] [Abstract][Full Text] [Related]
11. The 'MAP strategy' (Maximum aspiration of atherothrombus and adjunctive glycoprotein IIb/IIIa inhibitor utilization combined with prolonged inflation of balloon/stent) for preventing no-reflow in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: A retrospective analysis of seventy-one cases.
Potdar A; Sharma S
Indian Heart J; 2015 Dec; 67 Suppl 3(Suppl 3):S43-6. PubMed ID: 26995430
[TBL] [Abstract][Full Text] [Related]
12. Comparative Significance of Invasive Measures of Microvascular Injury in Acute Myocardial Infarction.
Maznyczka AM; Oldroyd KG; Greenwood JP; McCartney PJ; Cotton J; Lindsay M; McEntegart M; Rocchiccioli JP; Good R; Robertson K; Eteiba H; Watkins S; Shaukat A; Petrie CJ; Murphy A; Petrie MC; Berry C
Circ Cardiovasc Interv; 2020 May; 13(5):e008505. PubMed ID: 32408817
[TBL] [Abstract][Full Text] [Related]
13. Association of monocyte count on admission with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
Wang Z; Ren L; Liu N; Lei L; Ye H; Peng J
Kardiol Pol; 2016; 74(10):1160-1166. PubMed ID: 27160177
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Slow-Flow After Primary Percutaneous Coronary Intervention With Flow-Mediated Hyperemia: The Randomized RAIN-FLOW Study.
Gomez-Lara J; Gracida M; Rivero F; Gutiérrez-Barrios A; Muntané-Carol G; Romaguera R; Fuentes L; Marcano A; Roura G; Ferreiro JL; Teruel L; Brugaletta S; Alfonso F; Comín-Colet J; Gomez-Hospital JA
J Am Heart Assoc; 2023 Jul; 12(13):e030285. PubMed ID: 37345805
[TBL] [Abstract][Full Text] [Related]
16. Effect of Intravascular Cooling on Microvascular Obstruction (MVO) in Conscious Patients with ST-Elevation Myocardial Infarction Undergoing Primary PCI: Results from the COOL AMI EU Pilot Study.
Keeble TR; Karamasis GV; Noc M; Sredniawa B; Aradi D; Neskovic AN; Arheden H; Erlinge D; Holzer M
Cardiovasc Revasc Med; 2019 Sep; 20(9):799-804. PubMed ID: 30414797
[TBL] [Abstract][Full Text] [Related]
17. Relationship between R-wave peak time and no-reflow in ST elevation myocardial infarction treated with a primary percutaneous coronary intervention.
Çağdaş M; Karakoyun S; Rencüzoğullari İ; Karabağ Y; Yesin M; Uluganyan M; Gürsoy MO; Artaç İ; İliş D; Efe SÇ; Taşar O
Coron Artery Dis; 2017 Jun; 28(4):326-331. PubMed ID: 28207567
[TBL] [Abstract][Full Text] [Related]
18. Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Celik T; Balta S; Ozturk C; Kaya MG; Aparci M; Yildirim OA; Demir M; Unlu M; Demirkol S; Kilic S; Iyisoy A
Angiology; 2016 Aug; 67(7):683-9. PubMed ID: 26369341
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
20. Relationship between microvascular obstruction and adverse events following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: an individual patient data pooled analysis from seven randomized trials.
de Waha S; Patel MR; Granger CB; Ohman EM; Maehara A; Eitel I; Ben-Yehuda O; Jenkins P; Thiele H; Stone GW
Eur Heart J; 2017 Dec; 38(47):3502-3510. PubMed ID: 29020248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
